sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements." ;
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ;
    dce:title "BEL Framework Large Corpus Document" ;
    pav:authoredBy sub:_4 ;
    pav:version "20131211" .
  sub:_3 prov:value """Table 1. Genes regulated by thapsigargin according to microarray analysis in human VSMCs  Gene ID     Gene Name     Cluster     Fold Change DUSP1 (MKP-1)     MAP kinase phosphatase 1*     Hs.171695     1.975 DSCR1     Down syndrome critical region     Hs.282326     1.778 CYR61     Cysteine-rich protein 61*     Hs.8867     1.718 FN1     Fibronectin 1*     Hs.203717     1.667 GLT8D1     Glycosyltransferase 8 domain-containing 1     Hs.297304     1.563 KLF6     Kruppel-like factor 6     Hs.285313     1.559 PLK2     Pol-like kinase 2*     Hs.398157     1.553 CXCL2     Chemokine (C-X-C motif) ligand*     Hs.75765     1.538 TM4SF1     Transmembrane 4L six family member     Hs.351316     1.533 GEM     GTP-binding protein*     Hs.345139     1.53 FOS     v-fos FBJ murine osteosarcoma viral oncogene homology*     Hs.25647     1.52 ATF3     Activating transcription factor 3*     Hs.460     1.515 Genes significantly changed by ?1.5-fold when treated for 30 min with 100 nM thapsigargin compared with no treatment. In the case of multiple probe sets, exemplar is represented. VSMCs, vascular smooth muscle cells.  * Ca3+/cAMP response element (CRE)-containing consensus.""" ;
    prov:wasQuotedFrom pubmed:16461377 .
  sub:_4 rdfs:label "Selventa" .
  sub:assertion prov:hadPrimarySource pubmed:16461377 ;
    prov:wasDerivedFrom beldoc: , sub:_3 .
}